Weather of Arabia - The large British pharmaceutical company AstraZeneca acknowledged that its anti-coronavirus vaccine could result in rare side effects, according to a report published by the British newspaper The Telegraph. The company confirmed in documents submitted to the court that the Covishield vaccine may, in rare cases, lead to blood clots and a decrease in the number of blood platelets.
The Covishield vaccine, developed by AstraZeneca in collaboration with the University of Oxford during the Covid-19 pandemic, is produced by the Serum Institute of India and is widely used in India.
See also:
Ways to help you reduce the proximity of mosquitoes to your home
Answer: As early as March 2021, scientists first discovered a link between the vaccine and a new disease known as vaccine-induced thrombocytopenia and thrombosis (VITT), shortly after the COVID-19 vaccine began being rolled out.
Jimmy Scott, the first complainant in the case, claimed that he received the vaccine in April 2021; Which caused him a permanent brain injury after a blood clot, which prevented him from working, and the hospital even told his wife 3 times that he would die, according to his claim.
AstraZeneca is contesting the claims, but accepted in a legal document it submitted to the High Court in February that its coronavirus vaccine “can, in very rare cases, cause TTS”.
TTS, which stands for thrombosis with thrombocytopenia syndrome, is a rare condition that can cause people to develop blood clots and low platelet counts.
51 lawsuits have been filed before the Supreme Court, by families demanding compensation amounting to 100 million pounds sterling.
Read also:
Containers from a famous company contaminated with feces in France... What's the story?
Sources:
Arabia Weather App
Download the app to receive weather notifications and more..
English
